Skip to main content
MPLT
NASDAQ Life Sciences

Major Investor Catalyst4 Increases Stake to 47.9% in MapLight Therapeutics

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$12.817
Mkt Cap
$534.858M
52W Low
$9.1
52W High
$40.43
52W Position info
41% above low
Off High info
68% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

MPLT sits 41% above its 52-week low of $9.1.

Summary

Catalyst4, Inc. has significantly boosted its ownership in MapLight Therapeutics to 47.9% through a $15.3 million stock purchase, signaling high confidence in the company.


Key Events · Ownership and Investor Activity · MPLT

  • Increased Ownership

    Catalyst4, Inc. and its affiliates now beneficially own 20,906,689 shares, representing 47.9% of MapLight Therapeutics' common stock.

  • Significant Investment

    The reporting persons acquired an additional 1,209,225 shares for approximately $15.3 million in open market transactions between July 28-30, 2026.

  • Amended Disclosure

    This Schedule 13D/A updates a previous filing, noting a material increase in ownership percentage. The purchases were previously disclosed in a Form 4 on July 30, 2026.


Analysis · MPLT · Life Sciences

Catalyst4, Inc., a significant investor, has materially increased its beneficial ownership in MapLight Therapeutics through recent open market purchases totaling $15.3 million. This amendment to their Schedule 13D reveals their stake has grown to 47.9% of the company's common stock, indicating strong conviction in the company's prospects. This follows recent positive Phase 2 trial results for ML-007C-MA in schizophrenia.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MPLT was trading at $12.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $534.9M. The 52-week trading range was $9.10 to $40.43. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MPLT - Latest Insights

MPLT
Aug 18, 2026, 6:55 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $11.59
Real-time Price: $7.25 info
Change: -$4.34 (-37%) info
Market Cap: $404.035M info
MPLT
Aug 18, 2026, 6:51 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $11.59
Real-time Price: $7.25 info
Change: -$4.34 (-37%) info
Market Cap: $404.035M info
MPLT
Aug 13, 2026, 5:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.70
Real-time Price: $7.25 info
Change: -$4.45 (-38%) info
Market Cap: $404.035M info
MPLT
Aug 13, 2026, 4:51 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.70
Real-time Price: $7.25 info
Change: -$4.45 (-38%) info
Market Cap: $404.035M info
MPLT
Aug 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $11.82
Real-time Price: $7.25 info
Change: -$4.57 (-39%) info
Market Cap: $404.035M info